PMC9706390_01
Patient 1 with clinical atopic dermatitis manifestations at baseline (A) and after 9 months of dupilumab treatment (B).
gr1.jpg
PMC9706390_01_gr1.jpg
fig1
Physical examination revealed severe and generalized xerosis, excoriated erythematous papules, and nodules on the trunk and extremities associated with diffuse hyperpigmentation (Fig 1, A). Physical examination showed improvement in xerosis, reduction in hyperpigmentation and nodules with IGA 2, EASI 10, BSA 25%, Itch-VAS 0, and DLQI 5, and IGA 1, EASI 3, BSA 8, Itch VAS 0, and DLQI 0 after 3 and 6 months, respectively (Fig 1, B).
PMC9706390_02
PMC9706390_03